Home›Trial›NCT07008118
🔬NCT07008118Phase 1RECRUITING

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Study Summary

This study is being conducted to evaluate the safety and tolerability of INCA035784 in participants with myeloproliferative neoplasms.

Conditions
Myeloproliferative Neoplasms
Interventions / Drugs
INCA035784
View on ClinicalTrials.gov ↗
Sponsor
INCY
Incyte Corporation
Oncology
C60/100
Study Details
Enrollment120 participants
Primary Completion—
Lead SponsorIncyte Corporation
Data Retrieved2026-04-11 02:55:29.647358+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.